Gundlach B R, Reiprich S, Sopper S, Means R E, Dittmer U, Mätz-Rensing K, Stahl-Hennig C, Uberla K
Institut für Klinische und Molekulare Virologie, Universität Erlangen-Nürnberg, Erlangen, Germany.
J Virol. 1998 Oct;72(10):7846-51. doi: 10.1128/JVI.72.10.7846-7851.1998.
Live attenuated simian immunodeficiency viruses (SIV), such as nef deletion mutants, are the most effective vaccines tested in the SIV-macaque model so far. To modulate the antiviral immune response induced by live attenuated SIV vaccines, we had previously infected rhesus monkeys with a nef deletion mutant of SIV expressing interleukin 2 (SIV-IL2) (B. R. Gundlach, H. Linhart, U. Dittmer, S. Sopper, S. Reiprich, D. Fuchs, B. Fleckenstein, G. Hunsmann, S. Stahl-Hennig, and K. Uberla, J. Virol. 71:2225-2232, 1997). In the present study, SIV-IL2-infected macaques and macaques infected with the nef deletion mutant SIVDeltaNU were challenged with pathogenic SIV 9 to 11 months postvaccination. In contrast to the results with naive control monkeys, no challenge virus could be isolated from the SIV-IL2- and SIVDeltaNU-infected macaques. However, challenge virus sequences could be detected by nested PCR in some of the vaccinated macaques. To determine the role of immune responses directed against Env of SIV, four vaccinated macaques were rechallenged with an SIV-murine leukemia virus (MLV) hybrid in which the env gene of SIV had been functionally replaced by the env gene of amphotropic MLV. All vaccinated macaques were protected from productive infection with the SIV-MLV hybrid in the absence of measurable neutralizing antibodies, while two naive control monkeys were readily infected. Since the SIV-MLV hybrid uses the MLV Env receptor Pit2 and not CD4 and a coreceptor for virus entry, chemokine inhibition and receptor interference phenomena were not involved in protection. These results indicate that the protective responses induced by live attenuated SIV vaccines can be independent of host immune reactions directed against Env.
减毒活猿猴免疫缺陷病毒(SIV),如nef缺失突变体,是迄今为止在SIV-猕猴模型中测试的最有效的疫苗。为了调节减毒活SIV疫苗诱导的抗病毒免疫反应,我们之前用表达白细胞介素2的SIV的nef缺失突变体(SIV-IL2)感染了恒河猴(B.R. Gundlach、H. Linhart、U. Dittmer、S. Sopper、S. Reiprich、D. Fuchs、B. Fleckenstein、G. Hunsmann、S. Stahl-Hennig和K. Uberla,《病毒学杂志》71:2225-2232,1997)。在本研究中,接种疫苗9至11个月后,用致病性SIV对感染SIV-IL2的猕猴和感染nef缺失突变体SIVDeltaNU的猕猴进行攻击。与未免疫对照猴的结果相反,在感染SIV-IL2和SIVDeltaNU的猕猴中未分离到攻击病毒。然而,通过巢式PCR在一些接种疫苗的猕猴中可以检测到攻击病毒序列。为了确定针对SIV Env的免疫反应的作用,用一种SIV-鼠白血病病毒(MLV)杂交病毒对四只接种疫苗的猕猴进行再次攻击,其中SIV的env基因已被嗜异性MLV的env基因功能性取代。在没有可测量的中和抗体的情况下,所有接种疫苗的猕猴都受到保护,免受SIV-MLV杂交病毒的有效感染,而两只未免疫对照猴很容易被感染。由于SIV-MLV杂交病毒使用MLV Env受体Pit2而不是CD4和病毒进入的共受体,保护作用不涉及趋化因子抑制和受体干扰现象。这些结果表明,减毒活SIV疫苗诱导的保护反应可以独立于针对Env的宿主免疫反应。